AQUARO, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 5.739
AS - Asia 1.330
EU - Europa 1.312
SA - Sud America 310
Continente sconosciuto - Info sul continente non disponibili 127
AF - Africa 43
OC - Oceania 5
Totale 8.866
Nazione #
US - Stati Uniti d'America 5.648
SG - Singapore 590
RU - Federazione Russa 555
IT - Italia 436
HK - Hong Kong 269
BR - Brasile 262
CN - Cina 195
VN - Vietnam 159
FR - Francia 109
CA - Canada 51
DE - Germania 48
NL - Olanda 37
GB - Regno Unito 36
IN - India 34
FI - Finlandia 24
AR - Argentina 19
BD - Bangladesh 18
MX - Messico 16
PL - Polonia 11
LT - Lituania 9
ZA - Sudafrica 9
ES - Italia 8
IQ - Iraq 8
JP - Giappone 8
UA - Ucraina 8
JM - Giamaica 7
CL - Cile 6
EC - Ecuador 6
TR - Turchia 6
CR - Costa Rica 5
ID - Indonesia 5
KE - Kenya 5
RO - Romania 5
SE - Svezia 5
UZ - Uzbekistan 5
CO - Colombia 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
KZ - Kazakistan 4
MA - Marocco 4
PH - Filippine 4
SA - Arabia Saudita 4
SC - Seychelles 4
TZ - Tanzania 4
UY - Uruguay 4
AZ - Azerbaigian 3
DZ - Algeria 3
EG - Egitto 3
ET - Etiopia 3
KG - Kirghizistan 3
PS - Palestinian Territory 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
KR - Corea 2
NI - Nicaragua 2
PE - Perù 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
AD - Andorra 1
AM - Armenia 1
BS - Bahamas 1
GD - Grenada 1
GF - Guiana Francese 1
GH - Ghana 1
GM - Gambi 1
GN - Guinea 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MW - Malawi 1
MY - Malesia 1
NC - Nuova Caledonia 1
NP - Nepal 1
PA - Panama 1
PF - Polinesia Francese 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
SV - El Salvador 1
TG - Togo 1
TH - Thailandia 1
WS - Samoa 1
Totale 8.739
Città #
Dallas 3.014
San Jose 677
Council Bluffs 567
Ashburn 394
Hong Kong 268
Singapore 261
The Dalles 146
Santa Clara 144
Milan 98
Moscow 95
Lauterbourg 91
Hefei 83
Ho Chi Minh City 58
New York 58
Los Angeles 40
Rome 35
Hanoi 34
Amsterdam 32
São Paulo 31
Phoenix 30
Beijing 26
Orem 23
Da Nang 20
Naples 20
Chennai 19
Miano 19
Lappeenranta 17
Montreal 17
Assago 16
Chicago 15
Denver 14
Frankfurt am Main 14
Toronto 13
Brooklyn 12
Munich 12
London 11
Atlanta 10
Bologna 10
Piscataway 10
Warsaw 10
Brasília 9
Seattle 9
Boston 8
Tokyo 8
Washington 8
Charlotte 7
Falkenstein 7
Mexico City 7
Palermo 7
San Francisco 7
Turin 7
Belo Horizonte 6
Curitiba 6
Genoa 6
Haiphong 6
Venice 6
Ankara 5
Düsseldorf 5
Florence 5
Helsinki 5
Johannesburg 5
Kingston 5
Memphis 5
New Delhi 5
North Bergen 5
Paris 5
Stockholm 5
Tashkent 5
Buffalo 4
Campinas 4
Dar es Salaam 4
Honolulu 4
Houston 4
Montevideo 4
Mumbai 4
Nuremberg 4
Padua 4
Rio de Janeiro 4
Santiago 4
Verona 4
Baghdad 3
Baku 3
Baltimore 3
Bari 3
Birmingham 3
Bishkek 3
Bragança Paulista 3
Buenos Aires 3
Casablanca 3
Cleveland 3
Fortaleza 3
Goiânia 3
Guarulhos 3
Guayaquil 3
Hollywood 3
Louisville 3
Manchester 3
Mar del Plata 3
Milwaukee 3
Modena 3
Totale 6.746
Nome #
1,2,3-triazole-TSAO analogues: Synthesis and anti-HIV activity 2.798
Synthesis of novel N-Heterocyclic carbene-Ruthenium (II) complexes, “precious” tools with antibacterial, anticancer and antioxidant properties 100
New Therapies and Strategies to Curb HIV Infections with a Focus on Macrophages and Reservoirs 98
ANTIBACTERIAL AND ANTIVIRAL PHARMACEUTICAL COMPOSITION 95
Enhancing the Anticancer and Anti-Inflammatory Properties of Curcumin in Combination with Quercetin, for the Prevention and Treatment of Prostate Cancer 93
Triclosan: A Small Molecule with Controversial Roles 93
Impact of Cytochrome P450 Enzymes on the Phase I Metabolism of Drugs 92
COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies 92
N-Heterocyclic Carbene (NHC) Silver Complexes as Versatile Chemotherapeutic Agents Targeting Human Topoisomerases and Actin 92
Modulation of energetic and lipid pathways by curcumin as a potential chemopreventive strategy in human prostate cancer cells 89
The Ongoing Impact of COVID-19 on Pediatric Obesity 84
Silver and Gold Complexes with NHC-Ligands Derived from Caffeine: Catalytic and Pharmacological Activity 83
HIV-1 Structural Proteins or Cell-Signaling Factors? That Is the Question! 80
Are Nutraceuticals Effective in COVID‐19 and Post‐COVID Prevention and Treatment? 78
Cachrys spp. from Southern Italy: Phytochemical Characterization and JAK/STAT Signaling Pathway Inhibition 77
Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies 76
Potential PDE4B inhibitors as promising candidates against SARS-CoV-2 infection 76
Thidiazuron: New Trends and Future Perspectives to Fight Xylella fastidiosa in Olive Trees 71
Drugs for COVID-19: An Update 71
Antibiotic-Resistant ESKAPE Pathogens and COVID-19: The Pandemic beyond the Pandemic 70
Diarylureas: Repositioning from Antitumor to Antimicrobials or Multi-Target Agents against New Pandemics 70
Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin 69
Thymosin α 1 potentiates the release by CD8(+) cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection in vitro 66
N-Heterocyclic Carbene-Gold(I) Complexes Targeting Actin Polymerization 65
Mechanisms underlying of antiretroviral drugs in different cellular reservoirs with a focus on macrophages 65
The degree of HIV-1 amino acid variability is strictly related to different disease progression rates 64
Phosphatidylcholine Liposomes Down-Modulate CD4 Expression Reducing HIV Entry in Human Type-1 Macrophages 63
Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype- infection 61
Comparative antiviral activity of integrase inhibitors in human monocyte-derived macrophages and lymphocytes 61
Antiviral Profile of HIV Inhibitors in Macrophages: Implications for Therapy 57
S-adenosylhomocysteine hydrolase inhibitors interfere with the replication of human immunodeficiency virus type 1 through inhibition of the LTR transactivation 56
Expression of interleukin-15 and interleukin-15Rα in monocytes of HIV type 1-infected patients with different courses of disease progression 56
HIV-1 B-subtype capsid protein: a characterization of amino acid's conservation and its significant association with integrase signatures 56
Conversion of 2',3'-dideoxyadenosine (ddA) and 2',3'-didehydro-2',3'-dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus 55
Features of Pathogenesis of Human Viral Infections and Antiviral Drugs 55
Influenza virus A (H5N1): a pandemic risk? 54
Attivita’ di farmaci inibitori del virus dell’immunodeficienza umana in macrofagi umani e correlazione con l’efficacia clinica 54
Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo 53
Carbazole Derivatives as Antiviral Agents: An Overview 53
Il macrofago e l’infezione da HIV. Ruolo delle cellule lungo sopravviventi nella patogenesi e nella terapia 53
Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure 52
Different Patterns of HIV-1 Replication in MACROPHAGES is Led by Co-Receptor Usage 52
Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: new therapeutic strategies 52
Anti-nerve growth factor Ab abrogates macrophage mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice 51
Activity of the (R)-Enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine [(R)-PMPA] and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine [(R)-PMPDAP] against Human Immunodeficiency Virus in Different Human Cell Systems 51
Identification of gp120 polymorphisms in HIV-1 B subtype potentially associated with resistance to fostemsavir 51
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro 50
Cyclosaligenil-2’,3’-didehydro-2’,3’ – dideoxythymidine Monophosphate: efficient Intracellular Delivery of d4TMP 50
Red-blood cells mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to primary macrophages: efficiency, metabolism, and activity against human immunodeficiency virus or herpes simplex virus 50
The contribution of oxidative stress in apoptosis of human-cultured astroglial cells induced by supernatants of HIV-1-infected macrophages 50
Chloro-1,4-dimethyl-9H-carbazole Derivatives Displaying Anti-HIV Activity 48
Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4(+) T lymphocytes 48
Effects of Amprenavir on HIV-1 Maturation, Production and Infectivity Following Drug Withdrawal in Chronically-Infected Monocytes/Macrophages 48
Presence of 2’,5’-Bis-O-(tert-butyldimethilsylil)-3’-spiro-5”-(4”-amino-1”,2”-oxathiole-2”,2”-dioxide)(TSAO)-resistant virus strain in TSAO-inexperienced HIV patients 48
Intracellular GSH content and HIV replication in human macrophages 47
Activity of masked 2’-3’-Dideoxynucleoside Monophosphate Derivatives Against Human Immunodeficiency Virus in Resting Macrophages 47
Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist 47
Macrophages: a crucial reservoir for human immunodeficiency virus in the body 47
Different kinetics of viral replication and DNA integration in the main HIV-1 cellular reservoirs in the presence and absence of integrase inhibitors 47
Specific VpU codon changes were significantly associated with gp120 V3 tropic signatures in HIV-1 B-subtype 46
Potent antiviral activity of amprenavir in primary macrophages infected by human immunodeficiency virus 46
Viral Dynamic and mutations in the Pol Gene during primary HIV-1 infection 46
Antiretrovirus activity of novel class of acyclic pyrimidine nucleoside phosphonates 46
Identification of Pinosylvin in Pinus nigra subsp. laricio: A Naturally Occurring Stilbenoid Suppressing LPS-Induced Expression of Pro-Inflammatory Cytokines and Mediators and Inhibiting the JAK/STAT Signaling Pathway 46
Antimicrobial properties of the medicinal plant Cardiospermum halicacabum L: new evidence and future perspectives 45
Therapeutic strategies towards HIV-1 infection in macrophages 45
CCR5/CXCR4 dual antagonism for the improvement of HIV infection therapy 45
Nerve growth factor is an autocrine factor essential for the survival of macrophages infected by human immunodeficiency virus 45
Inhibition of Dual/Mixed Tropic HIV-1 Isolates by CCR5-Inhibitors in Primary Lymphocytes and Macrophages 44
Telomerase activity, hTERT expression, and phosphorylation are downregulated in CD4(+) T lymphocytes infected with human immunodeficiency virus type 1 (HIV-1) 44
oxidative stress and HIV infection:target pathways for novel therapies? 44
Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir 43
In vitro activity of inhibitors of late stages of the replication of HIV in chronically-infected macrophages 43
Identification of the novel KI Polyomavirus in paranasal and lung tissues 43
Understanding HIV compartments and reservoirs 43
Inhibition of the protease of human immunodeficiency virus blocks replication and infectivity of the virus in chronically-infected macrophages 43
The Role of HIV Infection in Neurologic Injury 43
Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibitor of STAT1 expression 43
Inhibition of replication of human immunodeficiency virus in primary monocyte-derived macrophages by different antiviral drugs, and comparative efficacy in lymphocytes 42
Does residual virus replication during successful HAART lead to HIV-1 genetic evolution? 42
The contribution of peroxynitrite generation in HIV replication in human primary macrophages 42
Highly Favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 (HIV-1) replication 41
Clinical implications of HIV dynamics and drug resistance in macrophages 41
Advances in macrophage and dendritic cell biology in HIV-1 infection stress key understudied areas in infection, pathogenesis, and analysis of viral reservoirs 41
HIV-1-associated dementia during HAART therapy 41
Improved antiviral activity of the aryloxymethoxyphosphoramidate (APA) prodrug of abacavir (ABC) is due to the formation of markeldy increased carbovir 5’-triphosphate metabolite levels 41
Effect of maraviroc on non-R5 tropic HIV-1: refined analysis of subjects from the phase IIb study A4001029 40
Intracellular metabolism of cyclosaligenyl 3’-azido-2’-3’-dideoxythymidine monophosphate, a prodrug of 3’-azido-2’-3’-dideoxythymidine (zidovudine) 40
Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus 40
Novel in vivo model for the study of human immunodeficiency virus type 1 transcription inhibitors: evaluation of new 6-desfluoroquinolone derivatives 40
Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors 40
The Potent Inhibition of Human Immunodeficiency Virus and Herpes Simplex Virus Type 1 by 9-(2-Phosphonylmethoxyethyl)Adenine (PMEA) in Primary Macrophages Is Determined by Drug Metabolism, Nucleotide Pools and Cytokines 39
Microbiological Characteristics and Physico-chemical Parameters of Fermented Milk Product Ergo-A Traditional Yogurt Product of Ethiopia 39
Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus 38
Gp41 sequence variability in HIV type 1 non-B subtypes infected patients undergoing enfuvirtide pressure 38
Profound anti-HIV-1 activity of DAPTA in monocytes/macrophages and inhibition of CCR5-mediated apoptosis in neuronal cells 38
NEUROAIDS: VIROLOGICAL ASPECTS OF HIV INFECTION 38
Mannose-specific plant lectins from the amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection 38
Human immunodeficiency virus infection and acquired immunodeficiency sindrome dementia complex: Role of cells of monocyte-macrophage lineage 37
HIV infection in macrophage: role of long-lived cells and related therapeutical strategies 37
Totale 8.246
Categoria #
all - tutte 29.586
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.586


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.428 0 0 0 0 145 167 288 79 411 77 105 156
2025/20266.031 109 920 2.283 471 164 257 636 142 330 357 352 10
2026/20271.407 41 158 365 843 0 0 0 0 0 0 0 0
Totale 8.866